Skip to main navigation Skip to main content
  • KSPTM
  • E-Submission

PHD : Parasites, Hosts and Diseases

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Th1/Th2"

Article category

Keywords

Publication year

Authors

"Th1/Th2"

Original Articles
Fasciola gigantica Fatty Acid Binding Protein (FABP) as a Prophylactic Agent against Schistosoma mansoni Infection in CD1 Mice
Ibrahim Rabia Aly, M. Diab, A. M. El-Amir, M. Hendawy, S. Kadry
Korean J Parasitol 2012;50(1):37-43.
Published online March 6, 2012
DOI: https://doi.org/10.3347/kjp.2012.50.1.37

Although schistosomicidal drugs and other control measures exist, the advent of an efficacious vaccine remains the most potentially powerful means for controlling this disease. In this study, native fatty acid binding protein (FABP) from Fasciola gigantica was purified from the adult worm's crude extract by saturation with ammonium sulphate followed by separation on DEAE-Sephadex A-50 anion exchange chromatography and gel filtration using Sephacryl HR-100, respectively. CD1 mice were immunized with the purified, native F. gigantica FABP in Freund's adjuvant and challenged subcutaneously with 120 Schistosoma mansoni cercariae. Immunization of CD1 mice with F. gigantica FABP has induced heterologous protection against S. mansoni, evidenced by the significant reduction in mean worm burden (72.3%), liver and intestinal egg counts (81.3% and 80.8%, respectively), and hepatic granuloma counts (42%). Also, it elicited mixed IgG1/IgG2b immune responses with predominant IgG1 isotype, suggesting that native F. gigantica FABP is mediated by a mixed Th1/Th2 response. However, it failed to induce any significant differences in the oogram pattern or in the mean granuloma diameter. This indicated that native F. gigantica FABP could be a promising vaccine candidate against S. mansoni infection.

Citations

Citations to this article as recorded by  Crossref logo
  • Investigating the Taenia solium Fatty Acid Binding Protein Superfamily for Their Immunological Outlook and Prospect for Therapeutic Targets
    Suraj S. Rawat, Gagandeep Singh, Amit Prasad
    ACS Omega.2024; 9(21): 22557.     CrossRef
  • Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya
    Bartholomew N. Ondigo, Rachael E. Hamilton, Edwin O. Magomere, Isaac O. Onkanga, Pauline N. Mwinzi, Maurice R. Odiere, Lisa Ganley-Leal
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Effect of regulatory T cells on the efficacy of the fatty acid-binding protein vaccine against Schistosoma japonicum
    Chun-lian Tang, Rong-hui Zhang, Zhi-ming Liu, Huang Jin, Long He
    Parasitology Research.2019; 118(2): 559.     CrossRef
  • Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems
    Belén Vicente, Julio López-Abán, Jose Rojas-Caraballo, Esther del Olmo, Pedro Fernández-Soto, Antonio Muro
    Parasites & Vectors.2016;[Epub]     CrossRef
  • Schistosomiasis in Egypt: A never-ending story?
    Ahmad A. Othman, Rasha H. Soliman
    Acta Tropica.2015; 148: 179.     CrossRef
  • Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant
    Miriam Tendler, Marilia Almeida, Andrew Simpson
    Frontiers in Immunology.2015;[Epub]     CrossRef
  • The transcriptome of Echinostoma caproni adults: Further characterization of the secretome and identification of new potential drug targets
    Gagan Garg, Dolores Bernal, Maria Trelis, Javier Forment, Javier Ortiz, M. Luz Valero, Laia Pedrola, Juan Martinez-Blanch, J. Guillermo Esteban, Shoba Ranganathan, Rafael Toledo, Antonio Marcilla
    Journal of Proteomics.2013; 89: 202.     CrossRef
  • Molecular characterization, functional expression, tissue localization and protective potential of a Taenia solium fatty acid-binding protein
    Oscar Illescas, Julio C. Carrero, Raúl J. Bobes, Ana Flisser, Gabriela Rosas, Juan P. Laclette
    Molecular and Biochemical Parasitology.2012; 186(2): 117.     CrossRef
  • 9,046 View
  • 95 Download
  • Crossref

An understanding of the nature of the immune response to asexual erythrocytic stages of malaria parasites will facilitate vaccine development by identifying which responses the vaccine should preferentially induce. The present study examined and compared the immune responses of NIH mice in either single or mixed infections with avirulent (DK) or virulent (DS) strains of Plasmodium chabaudi adami using the ELISA test for detecting and measurement of cytokines and antibody production. In both single and mixed infections, the study showed that both cell- and antibody-mediated responses were activated. In all experiments, an early relatively high level of IFN-γ and IgG2a during the acute phase of the infection, and later elevation of IL-4 and IgG1, suggested that there was a sequential Th1/Th2 response. However, in the avirulent DK strain infection a stronger Th1 response was observed compared to the virulent DS strain-infection or in mixed infections. In the virulent DS infection, there was a stronger Th2 response compared to that in the DK and mixed infections. The faster proliferation rate of the virulent DS strain compared to the DK strain was also evident.

Citations

Citations to this article as recorded by  Crossref logo
  • Macrophage Migration Inhibitory Factor: A Downregulator of Early T Cell-Dependent IFN-γ Responses in Plasmodium chabaudi adami (556 KA)-Infected Mice
    Diane Tshikudi Malu, Benoit Bélanger, François Desautels, Karine Kelendji, Esther Dalko, Jaime Sanchez-Dardon, Lin Leng, Richard Bucala, Abhay R Satoskar, Tatiana Scorza
    The Journal of Immunology.2011; 186(11): 6271.     CrossRef
  • 9,221 View
  • 58 Download
  • Crossref